Study Details

Additional Information

This is a research study for an investigational drug being developed for the treatment of obesity in adults. The purpose of this study is to evaluate the safety and tolerability (side effects) of single and multiple doses of the study drug at gradually increasing dose levels. The study will also measure how much of the study drug gets into the bloodstream, and how long it takes the body to get rid of it.

• Obese, otherwise healthy, Non-Smoking Adults, age 18-55. Females must be of non-childbearing potential

• BMI (body mass index) 30-39.9

• Join us for 31 nights, followed by 3 outpatient visits

• Compensation up to $10,586 may be provided for time and participation

Details

Call to schedule an appointment.

Group B5c
Check-In: Jun 22
Check-Out: Jul 23
Outpatient Visits: Jul 24, 26, 30,

Compensation Schedule:
Research unit Confinement (32 days x $316) - $10,112
Outpatient Visits (3 visits x $158) - $474